Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal - Announcement under Regulation 30 (LODR)-Analy...

20-May-2026|5:02PM

Intimation of Q4 & FY 2026 Earnings Call.

Hikal - Analysts/Institutional Investor Meet/Con. Cal...

20-May-2026|4:57PM

Hikal Limited has informed the Exchange about Schedule of meet

Hikal - Board Meeting Intimation for Considering Audi...

20-May-2026|4:40PM

Hikal Ltdhas informed BSE that the meeting of the Board of Directors of the

Hikal has submitted to BSE the Shareholding Pattern f...

16-Apr-2026|3:30PM

As of March 2026, 68.85% is owned by Indian Promoters and 31.15% by Public.

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug83.74237.44
Aarti Drug389.953,559.07
Aarti Pharma713.106,464.80
Abbott India27,830.0059,136.81
Accent Micro436.401,046.88
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..75.701.14
Tata Sm..62.450.55
Motilal..0.020.05
Bandhan..0.010.05
Motilal..0.000.00
More

Board Meetings

DatePurpose
27/05/2026Audited Results & F..
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
More